Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 Opioid-induced Constipation Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Opioid-induced Constipation Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Opioid-induced Constipation Overall Market Size
2.1 Global Opioid-induced Constipation Market Size: 2021 VS 2028
2.2 Global Opioid-induced Constipation Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Opioid-induced Constipation Players in Global Market
3.2 Top Global Opioid-induced Constipation Companies Ranked by Revenue
3.3 Global Opioid-induced Constipation Revenue by Companies
3.4 Top 3 and Top 5 Opioid-induced Constipation Companies in Global Market, by Revenue in 2021
3.5 Global Companies Opioid-induced Constipation Product Type
3.6 Tier 1, Tier 2 and Tier 3 Opioid-induced Constipation Players in Global Market
3.6.1 List of Global Tier 1 Opioid-induced Constipation Companies
3.6.2 List of Global Tier 2 and Tier 3 Opioid-induced Constipation Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Opioid-induced Constipation Market Size Markets, 2021 & 2028
4.1.2 Solid
4.1.3 Liquid
4.2 By Type - Global Opioid-induced Constipation Revenue & Forecasts
4.2.1 By Type - Global Opioid-induced Constipation Revenue, 2017-2022
4.2.2 By Type - Global Opioid-induced Constipation Revenue, 2023-2028
4.2.3 By Type - Global Opioid-induced Constipation Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Opioid-induced Constipation Market Size, 2021 & 2028
5.1.2 Drugstore
5.1.3 Hospital
5.1.4 Others
5.2 By Application - Global Opioid-induced Constipation Revenue & Forecasts
5.2.1 By Application - Global Opioid-induced Constipation Revenue, 2017-2022
5.2.2 By Application - Global Opioid-induced Constipation Revenue, 2023-2028
5.2.3 By Application - Global Opioid-induced Constipation Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Opioid-induced Constipation Market Size, 2021 & 2028
6.2 By Region - Global Opioid-induced Constipation Revenue & Forecasts
6.2.1 By Region - Global Opioid-induced Constipation Revenue, 2017-2022
6.2.2 By Region - Global Opioid-induced Constipation Revenue, 2023-2028
6.2.3 By Region - Global Opioid-induced Constipation Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Opioid-induced Constipation Revenue, 2017-2028
6.3.2 US Opioid-induced Constipation Market Size, 2017-2028
6.3.3 Canada Opioid-induced Constipation Market Size, 2017-2028
6.3.4 Mexico Opioid-induced Constipation Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Opioid-induced Constipation Revenue, 2017-2028
6.4.2 Germany Opioid-induced Constipation Market Size, 2017-2028
6.4.3 France Opioid-induced Constipation Market Size, 2017-2028
6.4.4 U.K. Opioid-induced Constipation Market Size, 2017-2028
6.4.5 Italy Opioid-induced Constipation Market Size, 2017-2028
6.4.6 Russia Opioid-induced Constipation Market Size, 2017-2028
6.4.7 Nordic Countries Opioid-induced Constipation Market Size, 2017-2028
6.4.8 Benelux Opioid-induced Constipation Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Opioid-induced Constipation Revenue, 2017-2028
6.5.2 China Opioid-induced Constipation Market Size, 2017-2028
6.5.3 Japan Opioid-induced Constipation Market Size, 2017-2028
6.5.4 South Korea Opioid-induced Constipation Market Size, 2017-2028
6.5.5 Southeast Asia Opioid-induced Constipation Market Size, 2017-2028
6.5.6 India Opioid-induced Constipation Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Opioid-induced Constipation Revenue, 2017-2028
6.6.2 Brazil Opioid-induced Constipation Market Size, 2017-2028
6.6.3 Argentina Opioid-induced Constipation Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Opioid-induced Constipation Revenue, 2017-2028
6.7.2 Turkey Opioid-induced Constipation Market Size, 2017-2028
6.7.3 Israel Opioid-induced Constipation Market Size, 2017-2028
6.7.4 Saudi Arabia Opioid-induced Constipation Market Size, 2017-2028
6.7.5 UAE Opioid-induced Constipation Market Size, 2017-2028
7 Players Profiles
7.1 AstraZeneca
7.1.1 AstraZeneca Corporate Summary
7.1.2 AstraZeneca Business Overview
7.1.3 AstraZeneca Opioid-induced Constipation Major Product Offerings
7.1.4 AstraZeneca Opioid-induced Constipation Revenue in Global Market (2017-2022)
7.1.5 AstraZeneca Key News
7.2 Takeda Pharmaceutical
7.2.1 Takeda Pharmaceutical Corporate Summary
7.2.2 Takeda Pharmaceutical Business Overview
7.2.3 Takeda Pharmaceutical Opioid-induced Constipation Major Product Offerings
7.2.4 Takeda Pharmaceutical Opioid-induced Constipation Revenue in Global Market (2017-2022)
7.2.5 Takeda Pharmaceutical Key News
7.3 Bausch Health
7.3.1 Bausch Health Corporate Summary
7.3.2 Bausch Health Business Overview
7.3.3 Bausch Health Opioid-induced Constipation Major Product Offerings
7.3.4 Bausch Health Opioid-induced Constipation Revenue in Global Market (2017-2022)
7.3.5 Bausch Health Key News
7.4 Abbott
7.4.1 Abbott Corporate Summary
7.4.2 Abbott Business Overview
7.4.3 Abbott Opioid-induced Constipation Major Product Offerings
7.4.4 Abbott Opioid-induced Constipation Revenue in Global Market (2017-2022)
7.4.5 Abbott Key News
7.5 Bayer
7.5.1 Bayer Corporate Summary
7.5.2 Bayer Business Overview
7.5.3 Bayer Opioid-induced Constipation Major Product Offerings
7.5.4 Bayer Opioid-induced Constipation Revenue in Global Market (2017-2022)
7.5.5 Bayer Key News
7.6 Boehringer Ingelheim
7.6.1 Boehringer Ingelheim Corporate Summary
7.6.2 Boehringer Ingelheim Business Overview
7.6.3 Boehringer Ingelheim Opioid-induced Constipation Major Product Offerings
7.6.4 Boehringer Ingelheim Opioid-induced Constipation Revenue in Global Market (2017-2022)
7.6.5 Boehringer Ingelheim Key News
7.7 C.B. Fleet
7.7.1 C.B. Fleet Corporate Summary
7.7.2 C.B. Fleet Business Overview
7.7.3 C.B. Fleet Opioid-induced Constipation Major Product Offerings
7.7.4 C.B. Fleet Opioid-induced Constipation Revenue in Global Market (2017-2022)
7.7.5 C.B. Fleet Key News
7.8 Cosmo Pharmaceuticals
7.8.1 Cosmo Pharmaceuticals Corporate Summary
7.8.2 Cosmo Pharmaceuticals Business Overview
7.8.3 Cosmo Pharmaceuticals Opioid-induced Constipation Major Product Offerings
7.8.4 Cosmo Pharmaceuticals Opioid-induced Constipation Revenue in Global Market (2017-2022)
7.8.5 Cosmo Pharmaceuticals Key News
7.9 Daewoong
7.9.1 Daewoong Corporate Summary
7.9.2 Daewoong Business Overview
7.9.3 Daewoong Opioid-induced Constipation Major Product Offerings
7.9.4 Daewoong Opioid-induced Constipation Revenue in Global Market (2017-2022)
7.9.5 Daewoong Key News
7.10 Daiichi Sankyo
7.10.1 Daiichi Sankyo Corporate Summary
7.10.2 Daiichi Sankyo Business Overview
7.10.3 Daiichi Sankyo Opioid-induced Constipation Major Product Offerings
7.10.4 Daiichi Sankyo Opioid-induced Constipation Revenue in Global Market (2017-2022)
7.10.5 Daiichi Sankyo Key News
7.11 GlaxoSmithKline
7.11.1 GlaxoSmithKline Corporate Summary
7.11.2 GlaxoSmithKline Business Overview
7.11.3 GlaxoSmithKline Opioid-induced Constipation Major Product Offerings
7.11.4 GlaxoSmithKline Opioid-induced Constipation Revenue in Global Market (2017-2022)
7.11.5 GlaxoSmithKline Key News
7.12 Ironwood Pharmaceuticals
7.12.1 Ironwood Pharmaceuticals Corporate Summary
7.12.2 Ironwood Pharmaceuticals Business Overview
7.12.3 Ironwood Pharmaceuticals Opioid-induced Constipation Major Product Offerings
7.12.4 Ironwood Pharmaceuticals Opioid-induced Constipation Revenue in Global Market (2017-2022)
7.12.5 Ironwood Pharmaceuticals Key News
7.13 Johnson and Johnson
7.13.1 Johnson and Johnson Corporate Summary
7.13.2 Johnson and Johnson Business Overview
7.13.3 Johnson and Johnson Opioid-induced Constipation Major Product Offerings
7.13.4 Johnson and Johnson Opioid-induced Constipation Revenue in Global Market (2017-2022)
7.13.5 Johnson and Johnson Key News
7.14 Merck
7.14.1 Merck Corporate Summary
7.14.2 Merck Business Overview
7.14.3 Merck Opioid-induced Constipation Major Product Offerings
7.14.4 Merck Opioid-induced Constipation Revenue in Global Market (2017-2022)
7.14.5 Merck Key News
7.15 Mundipharma
7.15.1 Mundipharma Corporate Summary
7.15.2 Mundipharma Business Overview
7.15.3 Mundipharma Opioid-induced Constipation Major Product Offerings
7.15.4 Mundipharma Opioid-induced Constipation Revenue in Global Market (2017-2022)
7.15.5 Mundipharma Key News
7.16 Nektar Therapeutics
7.16.1 Nektar Therapeutics Corporate Summary
7.16.2 Nektar Therapeutics Business Overview
7.16.3 Nektar Therapeutics Opioid-induced Constipation Major Product Offerings
7.16.4 Nektar Therapeutics Opioid-induced Constipation Revenue in Global Market (2017-2022)
7.16.5 Nektar Therapeutics Key News
7.17 Pfizer
7.17.1 Pfizer Corporate Summary
7.17.2 Pfizer Business Overview
7.17.3 Pfizer Opioid-induced Constipation Major Product Offerings
7.17.4 Pfizer Opioid-induced Constipation Revenue in Global Market (2017-2022)
7.17.5 Pfizer Key News
7.18 Progenics Pharmaceuticals
7.18.1 Progenics Pharmaceuticals Corporate Summary
7.18.2 Progenics Pharmaceuticals Business Overview
7.18.3 Progenics Pharmaceuticals Opioid-induced Constipation Major Product Offerings
7.18.4 Progenics Pharmaceuticals Opioid-induced Constipation Revenue in Global Market (2017-2022)
7.18.5 Progenics Pharmaceuticals Key News
7.19 Shionogi
7.19.1 Shionogi Corporate Summary
7.19.2 Shionogi Business Overview
7.19.3 Shionogi Opioid-induced Constipation Major Product Offerings
7.19.4 Shionogi Opioid-induced Constipation Revenue in Global Market (2017-2022)
7.19.5 Shionogi Key News
7.20 SLA Pharma
7.20.1 SLA Pharma Corporate Summary
7.20.2 SLA Pharma Business Overview
7.20.3 SLA Pharma Opioid-induced Constipation Major Product Offerings
7.20.4 SLA Pharma Opioid-induced Constipation Revenue in Global Market (2017-2022)
7.20.5 SLA Pharma Key News
7.21 Sucampo
7.21.1 Sucampo Corporate Summary
7.21.2 Sucampo Business Overview
7.21.3 Sucampo Opioid-induced Constipation Major Product Offerings
7.21.4 Sucampo Opioid-induced Constipation Revenue in Global Market (2017-2022)
7.21.5 Sucampo Key News
7.22 Synergy Pharmaceuticals
7.22.1 Synergy Pharmaceuticals Corporate Summary
7.22.2 Synergy Pharmaceuticals Business Overview
7.22.3 Synergy Pharmaceuticals Opioid-induced Constipation Major Product Offerings
7.22.4 Synergy Pharmaceuticals Opioid-induced Constipation Revenue in Global Market (2017-2022)
7.22.5 Synergy Pharmaceuticals Key News
7.23 Theravance
7.23.1 Theravance Corporate Summary
7.23.2 Theravance Business Overview
7.23.3 Theravance Opioid-induced Constipation Major Product Offerings
7.23.4 Theravance Opioid-induced Constipation Revenue in Global Market (2017-2022)
7.23.5 Theravance Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer